Marc Semigran

Affiliations

  • Chief Development Officer at Edgewise Therapeutics Inc. (EWTX), 2024-08-14
  • Chief Medical Officer at Renovacor Inc. (RCOR), 2022-12-06
  • Director at Social Capital Suvretta Holdings Corp. Iii (DNAC), 2021-06-30
  • Chief Medical Officer at Myokardia Inc (MYOK), 2019-02-12
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MYOK $60.00 3,600 Officer 0 2018-09-05 Filing
MYOK $59.49 41,400 Officer 0 2018-09-04 Filing